EDTUTC-4 New YorkLog in Sign up

GMAB
Genmab A/S ADS
stockNASDAQADR

Market OpenOct 28, 2026 12:26:09 PM EDT

57.83USD+29.449%(+13.16)18,721,422

Pre-marketOct 28, 2026 9:28:30 AM EDT

44.66USD-0.022%(-0.01)

57.73Bid58.00Ask0.27Spread

Loading…

Loading…

35.50B

Healthcare

Biotechnology

HQ

Copenhagen, Koebenhavn V, Denmark

1,846

Previous Close

$44.75

Beta

0.86

52-Week High

$45.45 2026-10-26

52-Week Low

$23.62 2026-06-03

SMA 50

$35.71

SMA 200

$30.17

Avg. Vol 10D

5.11M

Avg. Vol 30D

4.41M

Avg. Vol 90D

2.94M

Relative Vol

4.24

614.90M

587.09M

95.48%

6,598,711

Short Interest %

1.12%

1.34

On/Off Exchange

60%/40%

59.46%

Short Vol % (off-exch)

47.52%

0.4900%

3,400,000

3,542

6,880

25,319

Nov 5, 2026 (8d)

Oct 28, 2026

10:10 AM EDTGenmab says head and neck cancer drug cuts death risk by 50% with Merck’s Keytruda ·

Seeking Alpha

Oct 27, 2026

06:47 AM EDTGenmab Reaches Analyst Target Price ·

BNK Invest

Oct 25, 2026

02:56 PM EDTGenmab, Incyte team up to develop experimental colorectal cancer treatment ·

Seeking Alpha

Oct 24, 2026

08:27 AM EDTGenmab, Incyte Partner On Trial Of Petosemtamab Combination In KRAS G12D-Mutated Colorectal Cancer ·

RTTNews

Oct 23, 2026

03:27 PM EDTGenmab rises, Corcept falls on late-stage antibody-conjugate data for ovarian cancer ·

Seeking Alpha

GMAB Profile

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

GMAB Performance

Period	Price	Date	Change	Beta
1W	39.57	2026-10-21	+45.92%	-1.410
1M	35.36	2026-09-28	+63.29%	1.149
3M	29.00	2026-07-28	+99.10%	0.719
6M	26.79	2026-04-28	+115.53%	0.385
1Y	29.13	2025-10-28	+98.21%	0.861
2Y	23.14	2024-10-28	+149.52%	—
5Y	44.43	2021-10-28	+29.96%	0.702

GMAB Stock Summary

Genmab A/S ADS (NASDAQ:GMAB) stock price today is $57.74, and today's volume is 18,676,965. GMAB is up 29.257% today. The 30 day average volume is 4.41M. GMAB market cap is $35.50B with 614.90M shares outstanding.